Mirae Asset Global Etfs Holdings Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 84,941 shares of RXRX stock, worth $665,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,941Holding current value
$665,937% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
291Shares Held
239MCall Options Held
984KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$257 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$198 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$169 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$136 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$121 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.41B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...